TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $249,000 | -4.6% | 2,366 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $261,000 | -39.6% | 2,366 | -20.2% | 0.01% | -37.5% |
Q2 2016 | $432,000 | +94.6% | 2,966 | +91.7% | 0.01% | +60.0% |
Q1 2016 | $222,000 | -10.1% | 1,547 | -3.3% | 0.01% | 0.0% |
Q4 2015 | $247,000 | – | 1,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |